NCT05902728View on ClinicalTrials.gov

Study on Food Influence and Drug-drug Interaction of HLX208 Tablets in Chinese Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 4, 2023

Primary Completion Date

December 19, 2023

Study Completion Date

December 19, 2023

Conditions
NSCLC
Interventions
DRUG

HLX208

Subjects will receive treatment HLX208 900 mg in the fast state followed by 7 days washout ，then receive treatment HLX208 900 mg in the fed state

DRUG

HLX208

Subjects will receive treatment HLX208 900 mg in the fed state followed by 7 days washout ，then receive treatment HLX208 900 mg in the fast state.

DRUG

HLX208

450 mg

DRUG

HLX208

900 mg

DRUG

Itraconazole 200 mg

200 mg

DRUG

Rifampicin

600mg

Trial Locations (1)

Unknown

The First Affiliated Hospital of Soochow University, Suzhou

All Listed Sponsors
lead

Shanghai Henlius Biotech

INDUSTRY